Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ABOS
ABOS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABOS News
Acumen Pharmaceuticals Files to Sell 10.83M Shares of Common Stock
3d ago
seekingalpha
Acumen Pharmaceuticals Q4 2025 Earnings Call Insights
3d ago
seekingalpha
Acumen Pharmaceuticals FY 2025 Earnings Beat Expectations
4d ago
seekingalpha
ACUMEN PHARMACEUTICALS INC ANTICIPATES TOPLINE RESULTS FOR ALTITUDE-AD PHASE 2 STUDY BY LATE 2026
4d ago
moomoo
ACUMEN PHARMACEUTICALS, INC. Reports FY Operating Expenses of $123.832 Million
4d ago
moomoo
Acumen Pharmaceuticals Announces Financial Results and Business Highlights for the Year Ending December 31, 2025
4d ago
moomoo
NASDAQ 100 Pre-Market Indicator Rises Significantly
Mar 16 2026
NASDAQ.COM
Acumen Pharmaceuticals Raises $35.75 Million for Alzheimer's Drug Development
Mar 16 2026
NASDAQ.COM
Healthcare Stocks Surge in After-Hours Trading
Jan 28 2026
NASDAQ.COM
Wall Street Analysts Adjust Ratings
Jan 27 2026
Benzinga
Alumis Inc. (ALMS) Shares Surge 17.33% on Phase 3 Clinical Trial Data Announcement
Jan 06 2026
NASDAQ.COM
Healthcare Stocks Surge in After-Hours Trading: KYMR, OCUL, POAI Lead the Gains
Dec 08 2025
NASDAQ.COM
Acumen Pharmaceuticals Announces Financial Results and Business Highlights for Q3 2025
Nov 12 2025
Newsfilter
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Oct 23 2025
NASDAQ.COM
Biotech Surge on Friday: Clinical Advancements Drive Afternoon Gains
Sep 29 2025
NASDAQ.COM
Biotech Stocks Rise After Hours Following Trial News and Strategic Developments
Sep 24 2025
NASDAQ.COM
Show More News
